Home > Healthcare > Drug Device Combination > Therapeutic Systems > Cold Pain Therapy Market

Cold Pain Therapy Market Trends

Report ID: GMI10118
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Cold Pain Therapy Market Trends

The demand for safer pain management modalities is driving the growth of the cold pain therapy industry, as patients and healthcare providers increasingly seek alternatives to traditional methods.

Innovations in portable and wearable cryotherapy devices have made it easier for patients to receive cold therapy on-the-go. These devices are designed for targeted therapy, enhancing their effectiveness?.
New systems incorporate smart technology to monitor and adjust the temperature, ensuring optimal treatment and preventing tissue damage.
The development of devices that combine cold therapy with compression have been shown to improve outcomes by enhancing the reduction of inflammation and swelling. This combination is particularly beneficial for post-surgical recovery and sports injuries.
Furthermore, advancements in reusable and eco-friendly cold packs cater to the growing demand for sustainable healthcare solutions. These durable products reduce waste and support environmental responsibility. These advancements are collectively driving market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Cold pain therapy industry size was worth USD 1.9 billion in 2023 and will grow at 4.8% CAGR between 2024 and 2032, driven by the rising prevalence of sports injuries and musculoskeletal disorders along with the increasing demand for effective pain management solutions.

The musculoskeletal disorders segment recorded USD 777.4 million in 2023, primarily due to the high prevalence of conditions like arthritis, back pain, and tendonitis and increasing awareness of the benefits in reducing inflammation and accelerating recovery.

North America cold pain therapy industry size was USD 676.2 million in 2023, propelled by the high prevalence of sports injuries and musculoskeletal disorders, advanced healthcare infrastructure, coupled with significant investments in R&D of innovative cold therapy products.

Bird & Cronin, LLC, Breg, Inc., Cardinal Health, Compass Health Brands, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Consumer Inc., Performance Health, Polar Products Inc., Rapid Aid, Romsons Group of Industries, and Sanofi among others.